AI-generated summary
The authors studied 15 volunteers who received 808 nm diode laser therapy to both tibias, measuring circulating CD-34+ cells and macrophages in blood samples. They report that CD-34+ cells and macrophages rose significantly after treatment, with CD-34+ cells peaking at 2 to 4 days. The study is a pilot, so the authors frame the results as preliminary.
- Participants
- 15
- Who or what was studied
- 15 volunteers (humans)
- Wavelengths
- 808 nm
- Limits stated in the abstract
- This is a pilot study with a small sample, and the abstract does not report a control group or whether the cell increases translate into clinical benefit.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Pilot study, Trial registration, Wavelength, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.